Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novartis and Albumedix Sign Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Novartis and Albumedix Sign Agreement

To evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis technology platform

By: Betsy Louda

, Contract Pharma

Novartis and Albumedix have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedix’s Veltis technology platform and associated technologies.
 
Novartis will evaluate molecules in combination with Albumedix´s engineered albumin variants for enhanced delivery. Beyond the modulation of pharmacokinetic profiles, the potential for novel routes of administration and mechanisms of action will be assessed. Novartis will evaluate Albumedix’s Veltis technology across multiple therapeutic areas and against multiple targets.
 
“This collaboration is an excellent example of how our Veltis technology platform holds great potential for optimizing the therapeutic performance of pharmaceuticals across a broad range of targets and indications” commented Dr. Phil Morton, chief technology officer, Albumedix. “We look forward to a strong collaboration with the various research teams at Novartis for the advancement of albumin-enabled therapeutics.”

 
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters